Technology company Gentex announces acquisition of ocular device developer eSight

News
Article

eSight, a wearable assistive technology company, produces comprehensive equipment for patients with over 20 ocular disorders

An ophthalmologist helps a patient complete a vision test. Image credit: ©zinkevych – stock.adobe.com

Gentex will showcase eSight's ocular solutions at the Consumer Electronics Show (CES) in Las Vegas, Nevada. Image credit: ©zinkevych – stock.adobe.com

Gentex Corp. announced this week it has acquired the assets of eSight, a Toronto, Canada-based provider of vision enhancement technologies, to develop and manufacture the next generation of mobile electronic eyewear designed to help people living with visual impairments.

According to a news release, US-based Gentex will feature eSight’s next-gen technology at the Consumer Electronics Show (CES) 2024.1

Gentex is a technology company and a long-time supplier of electro-optical products for the global automotive, aerospace, and fire protection industries. It is best known for supplying nearly every major automaker with connected-car technologies and advanced electronic features that optimize driver vision and enhance driving safety.1

According to the company, eSight is a wearable assistive technology that allows people living with visual impairments to stay on the go while performing the tasks of daily living.

The medical equipment enhances vision for individuals with over 20 distinct ocular disorders, frequently enabling users to attain 20/20 vision. eSight eyewear combines a high-definition camera, proprietary algorithms, and a powerful processing platform to relay and magnify real-time imagery onto two high-resolution screens positioned before each eye, resulting in enhanced binocular vision.1

“For many years, our expertise in vision technology has been key in developing automotive solutions that improve driver safety,” said Neil Boehm, chief technology officer at Gentex. “Our acquisition of eSight is a strategic move to leverage this expertise in the healthcare industry to address the challenges of vision impairment, furthering our commitment to enhancing visual safety and quality of life.”

Gentex has applied its innovative capabilities in digital vision, software development, and industrial design to advance the development of eSight eyewear in a partnership that was originally announced in January 2022. The collaboration has focused on reducing device size, improving design, enhancing overall system performance, and applying Gentex’s advanced manufacturing skill sets to help improve cost.

Aaron Tutwiler, eSight’s former chief executive officer, pointed out that Gentex’s purchase of eSight is an exciting development for everyone involved.

“Millions of people experience the challenges of living with low vision,” Tutwiler said in a news release. “Gentex’s specialized knowledge and advanced capabilities in engineering, combined with its highly advanced manufacturing capabilities will improve eSight functionality and affordability to further expand the reach of those we can impact with our life-changing technology.”

According to the news release, the Consumer Electronics Show runs January 9-12 in Las Vegas.

Reference

1. Gentex Announces eSight Acquisition Set to Showcase Advanced Vision Tech at CES 2024. newsroom.gentex.com. Accessed January 8, 2024. https://newsroom.gentex.com/posts/pressreleases/gentex-announces-esight-acquisition-set-to-sh

Newsletter

Join ophthalmologists across Europe—sign up for exclusive updates and innovations in surgical techniques and clinical care.

Recent Videos
SriniVas R. Sadda, MD, FARVO, shares key points from his retina presentation at the International SPECTRALIS Symposium
Robert Sergott, MD, describes fluorescence lifetime imaging ophthalmoscopy (FLIO) and the International SPECTRALIS Symposium – And Beyond (ISS) in Heidelberg, Germany.
Rayaz Malik, MBChB, PhD, a professor of medicine at Weill Cornell Medicine - Qatar, spoke with Ophthalmology Times Europe about his presentation. It's titled "An eye on neurodegenerative diseases: Challenging the dogma" at the International SPECTRALIS Sympsoium. In conversation with Hattie Hayes, Ophthalmology Times Europe
Anat Loewenstein, MD, describes her presentation on remote imaging for age-related macular degeneration and geographic atrophy at the International SPECTRALIS Symposium, in conversation with Hattie Hayes of Ophthalmology Times Europe
Tyson Brunstetter, OD, PhD, a US Navy Aerospace Optometrist at the NASA Johnson Space Center in Houston, Texas, shares key takeaways from his keynote at the International SPECTRALIS Symposium (ISS)
Rayaz Malik, MBChB, PhD, shares his presentation, titled An eye on neurodegenerative diseases: Challenging the dogma, at this year's International SPECTRALIS Symposium
At the Retina World Congress, Siegfried Priglinger, MD, speaks about ensuring the best outcomes for preschool-aged patients
At the 2025 ASCRS meeting, Robert Ang, MD said small aperture IOLs can benefit all patients, especially those with complex corneas or who have undergone previous corneal refractive surgery
Viha Vig, MBChB graduate student at the University of Auckland, New Zealand, discusses her poster presentation on the relationship between mitochondiral disease, Alzheimer disease, and other types of dementia.
Alfredo Sadun, MD, PhD, chief of Ophthalmology at the Doheny Eye Institute, University of California Los Angeles, shared exciting new research with the Eye Care Network during the Association for Research in Vision and Ophthalmology (ARVO) meeting on the subject of Leber hereditary optic neuropathy (LHON).
© 2025 MJH Life Sciences

All rights reserved.